Revolution Medicines plans European rollout of pancreatic cancer drug
Revolution Medicines is preparing to launch its pancreatic cancer drug across Europe after securing a positive recommendation from EU regulators. Revolution Medicines is laying the groundwork for a broad European commercial rollout of its pancreatic cancer drug, signaling confidence in its ability to bring the…
Full story on the publisher’s site.